Automated Prime Editing Type V Dual-Deaminase Foundry Cap Rate 2026

Underwrite GMP Class A/B continuous synthetic dual-cytidine/adenine deaminase prime editing (PASSIGE / TwinPE) viral vector suites, $605/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

TwinPE Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP TwinPE Foundry Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation